2 exciting growth stocks that could fly high!

Growth stocks possess the potential to become mammoths their space, whilst providing market-beating capital growth and dividends.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Businesswoman calculating finances in an office

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Two growth stocks I think possess exciting potential are Experian (LSE: EXPN) and CVS Group (LSE: CVSG). Here’s why I plan to snap up some shares as soon as I have some available capital.

Experian

You may think of Experian as one of the largest credit score checking services, which is correct. However, there’s much more to the business and this is where the growth potential really excites me.

The shares are up 13% over a 12-month period, climbing from 2,825p at this time last year, to current levels of 3,235p.

In the digital world we live in, data is arguably one of the most coveted commodities and Experian has access to bucket loads of it! Credit scoring is already a great tool it offers and has helped the firm grow massively. With the AI revolution ramping up, the firm potentially has endless products and services it could provide with the data it possesses, which could boost share price, performance, and payouts.

To date, Experian’s excellent market share and growth has helped it perform well and record excellent organic growth. Plus, at present, there’s a dividend yield of 1.3% on offer. This isn’t the highest but could grow, in line with the business. However, dividends are never guaranteed.

From a bearish perspective, Experian shares trade for a premium on a price-to-earnings ratio of 30. Any bad news could send the shares tumbling. Conversely, I’m of the belief that sometimes you must pay a premium for quality companies. Furthermore, a bigger worry is the firm’s debt levels, standing close to £3.5bn. Paying down debt during times of higher interest can be costlier, and could take priority over growth aspirations.

So yes, I could wait for the shares to dip, but I don’t think they will. Barring a major issue, the only way is up for Experian shares, in my opinion.

CVS Group

CVS is a veterinary service provider to help us look after our pets. The business is split into four divisions, veterinary practices, laboratories, crematoria, and online retail.

The shares are down 16% over a 12-month period, from 1,918p at this point last year, to 1,685p as I write.

CVS’s growth potential is sky high, if you ask me. Firstly, pet ownership has never been higher than now, at least in the UK. Our pets need the same love, attention, and amenities that we do! That leads me nicely onto my next point, which is CVS’s multi faceted offering. This ranges from general healthcare, unfortunate but essential funeral services, as well as retail for owners to buy essentials and spoil their pets!

The company’s organic and acquisition-led journey has been impressive to date. However, the latter is something I do consider risky. When acquisitions don’t work out, they can be costly financially, as well as have lasting damage to investor sentiment and potentially returns too.

Its half year update released yesterday was positive. For the six months ended 31 December 2023, four new acquisitions were completed in Australia as the company broadened its footprint. Revenue and like-for-like sales increased by 11% and 6%. Furthermore, membership numbers increased too.

CVS looks well positioned to benefit from rising pet ownership numbers and there’s no telling where the shares could go, especially when volatility dissipates.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Sumayya Mansoor has no position in any of the shares mentioned. The Motley Fool UK has recommended Experian Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Stack of one pound coins falling over
Investing Articles

2 penny shares I think could shine in 2025

I have my eye on a few penny shares, as I'm thinking that the year ahead could turn out to…

Read more »

Investing Articles

2 ISA strategies for success in 2025

The ISA is a great vehicle for our investments, sheltering our returns from tax and providing us with the opportunity…

Read more »

Investing Articles

Here’s how an investor could start building a £10,000 second income for £180 per month in 2025

Our writer illustrates how an investor could put under £200 each month into shares and build a long-term five-figure passive…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Here’s how I’m finding bargain shares to buy for 2025!

Our writer takes a fairly simply approach when it comes to hunting for cheap shares to buy for his portfolio.…

Read more »

A graph made of neon tubes in a room
Investing Articles

Up 262%! This lesser-known energy company is putting other S&P 500 stocks to shame

Our writer delves into the rationale behind the parabolic growth of this under-the-radar S&P 500 energy company. The reason isn’t…

Read more »

Investing Articles

Just released: December’s small-cap stock recommendation [PREMIUM PICKS]

We believe the UK small-cap market offers a myriad of opportunities across a wide range of different businesses and industries.

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

£20k of savings? Here’s how an investor could turn that into passive income of £5k a year

A £20k lump sum, invested in a mix of blue-chip shares with a long-term approach, could generate thousands of pounds…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Is the BP share price set for a 75% jump?

The highest analyst target for BP shares in 2025 is 75% above the current price. So should investors consider buying…

Read more »